99 related articles for article (PubMed ID: 6547147)
1. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis.
Bouillon R; Auwerx J; Dekeyser L; Fevery J; Lissens W; De Moor P
J Clin Endocrinol Metab; 1984 Jul; 59(1):86-9. PubMed ID: 6547147
[TBL] [Abstract][Full Text] [Related]
2. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.
Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB
Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499
[TBL] [Abstract][Full Text] [Related]
3. Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis.
Fonseca V; Epstein O; Gill DS; Menon RK; Thomas M; McIntyre N; Dandona P
J Clin Endocrinol Metab; 1987 May; 64(5):873-7. PubMed ID: 3494037
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
Levin A; Bakris GL; Molitch M; Smulders M; Tian J; Williams LA; Andress DL
Kidney Int; 2007 Jan; 71(1):31-8. PubMed ID: 17091124
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone and cirrhosis of the liver.
Kirch W; Höfig M; Ledendecker T; Schmidt-Gayk H
J Clin Endocrinol Metab; 1990 Dec; 71(6):1561-6. PubMed ID: 2229313
[TBL] [Abstract][Full Text] [Related]
6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Role of change in vitamin D metabolism with age in calcium and phosphorus metabolism in normal human subjects.
Fujisawa Y; Kida K; Matsuda H
J Clin Endocrinol Metab; 1984 Oct; 59(4):719-26. PubMed ID: 6541227
[TBL] [Abstract][Full Text] [Related]
9. Influence of vitamin D on parathyroid function in the elderly.
Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
[TBL] [Abstract][Full Text] [Related]
10. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration.
Bouillon R; Van Assche FA; Van Baelen H; Heyns W; De Moor P
J Clin Invest; 1981 Mar; 67(3):589-96. PubMed ID: 6894152
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D and vitamin D-binding protein levels and mineral metabolism after partial and total gastrectomy.
Imawari M; Kozawa K; Akanuma Y; Koizumi S; Itakura H; Kosaka K
Gastroenterology; 1980 Aug; 79(2):255-8. PubMed ID: 6893189
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.
Findling JW; Adams ND; Lemann J; Gray RW; Thomas CJ; Tyrrell JB
J Clin Endocrinol Metab; 1982 May; 54(5):1039-44. PubMed ID: 6977549
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease.
Mawer EB; Klass HJ; Warnes TW; Berry JL
Clin Sci (Lond); 1985 Nov; 69(5):561-70. PubMed ID: 2996827
[TBL] [Abstract][Full Text] [Related]
14. The measurement of the vitamin D-binding protein in human serum.
Bouillon R; van Baelen H; de Moor P
J Clin Endocrinol Metab; 1977 Aug; 45(2):225-31. PubMed ID: 885987
[TBL] [Abstract][Full Text] [Related]
15. [Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone].
Louboutin JY; Feuillu A; Allain H; Bernat M; Meadeb J; Pawlotsky Y
Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):707-13. PubMed ID: 6256846
[TBL] [Abstract][Full Text] [Related]
16. Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function.
Korkor A; Schwartz J; Bergfeld M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
J Clin Endocrinol Metab; 1983 Mar; 56(3):496-500. PubMed ID: 6822651
[TBL] [Abstract][Full Text] [Related]
17. Calcium and vitamin D homeostasis in patients with heavy proteinuria.
Saha H
Clin Nephrol; 1994 May; 41(5):290-6. PubMed ID: 8050209
[TBL] [Abstract][Full Text] [Related]
18. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
[TBL] [Abstract][Full Text] [Related]
20. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease.
Diamond T; Stiel D; Mason R; Lissner D; Bikle D; Wilson S; Posen S
J Clin Endocrinol Metab; 1989 Dec; 69(6):1234-9. PubMed ID: 2584358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
